Synthesis and antimicrobial activity of 5-(2’-n-butyl-4’-chloro-1’-H-imidazol-5’-yl)-3-aryl-4,5-dihydro-{1-H/1-acetyl/1-phenyl}-pyrazoles

• Autorzy: Joshi A.K. , Purohit D.M.
• Języki publikacji: EN

Abstrakty

EN

5-(2’-n-butyl-4’-chloro 1’-H-imidazol- 5’-yl)-3-aryl-4, 5-dihydro-1-H-pyrazoles. (2a-2j); 1-[5’-(2”-n-butyl-4”- chloro-1”-H-imidazol-5”-yl)-3’-Aryl-4’, 5’-dihydro-1’-H-pyrazol-1-yl]-ethanones. (3a-3j); 5-(2’-n-butyl-4’-chloro-1’-H-imidazol-5’-yl)-3-Aryl-1-phenyl-4, 5-dihydro-1-H-pyrazoles. (4a-4j) have been synthesized. The products have been assayed for their antimicrobial activity against Gram +ve bacteria and Gram –ve bacteria and antifungal activity. The products have been characterised by IR, 1HNMR, Mass Spectra and TLC.

• Wydawca: -
• Czasopismo: World News of Natural Sciences
• Rocznik: 2021
• Tom: 35
• Opis fizyczny: p.38-47,fig.,ref.

Twórcy

autor

Joshi A.K.

• Department of Chemistry, Shree M. and N. Virani Science College, Rajkot - 360005, Gujarat, India

autor

Purohit D.M.

• Department of Chemistry, Shree M. and N. Virani Science College, Rajkot - 360005, Gujarat, India

Bibliografia

• [1] J. Panda, S. V. Srinivas, M. E. Rao. Journal of Indian Chemical Society 79(9) (2002) 770-771, Chemical Abstracts 138 (2003) 153499n.
• [2] F. F. Barsoum, H. M. Hosni, A. S. Girgis. Bio-organic Medicinal Chemistry 14(24) (2006) 8176-8175
• [3] A. A. Bekhit, H. H. Ashour, A. A. Guemei. Arch. Pharm. (Weinheim) 338(4) (2005) 167-174
• [4] A. Roman. Pharmazie 45 (1990) 214
• [5] O. Ruhoglu, Z. Ozdemir, A. A. Bilgin. Arzneimittelforschung 55(8) (2005) 431-436
• [6] H. G. Garg and P. P. Singh. Journal of Chemical Society 2 (1936) 1141
• [7] D. B. Reddy, T. Senshuna and M. V. Ramma Reddy. Indian Journal of Chemistry 30B (1991) 46
• [8] W. I. Ronald, A. Adriano. Chemical Abstracts 126 (1997) 181346f
• [9] H. M. Mokhtar, H. M. Faidallah. Pharmazie 42 (1987) 482
• [10] D. Francois, Patent Schrift (Switz). Chemical Abstracts 117 (1992) 90276f
• [11] G. Ayses, D. Seref, C. Gultaze, E. Kevser, V. Kamil. European Journal of Medicinal Chemistry 35 (2002) 359-364
• [12] S. S. Nayal and C. P. Singh. Asian Journal of Chemistry 11(1) (1999) 207-212
• [13] O. A. Fathalla, S. M. Awad, M. S. Mohamed. Arch. Pharm. Res. 28(11) (2005) 1205-1212
• [14] P. Desaea, A. Nunrich, M. Carderny and G. Devaux. European Journal of Medicinal Chemistry 25 (1990) 285
• [15] B. Kalluraya, R. Chimabalkar, G. Rai, R. Gururaja, S. Shenoy. Journal of Indian Council Chemistry 18(2) (2001) 39-43
• [16] K. Wellinga, H. H. Eussen Jacobus. European Patient Ep 269 (1988) 141 Chemical Abstracts 110 (1989) 8204
• [17] Y. Hiroyuti, O. Mocoto. European Patient Appl. Ep (1988) 295695 Chemical Abstracts 111 (1989) 23510
• [18] A. Budakoti, M. Abid, A. Azam, B. Hans, R. Rolf and R. Rudolf. US. Patient 3 (1974) 822 283 Chemical Abstracts 81 (1974) 105494r
• [19] K. Zalgislaw and V. Seffan. Acta. Pol. Pharm. 36(6) (1979) 645 Chemical Abstracts 93 (1980) 204525e
• [20] A. L. Barry; The Antimicrobial Susceptibility test, principle and practices. ELBS04th Edition) (1976) 180-193